Cargando…

miR-195 is a key regulator of Raf1 in thyroid cancer

Proto-oncogene Raf1 serves as a part of the mitogen-activated protein kinases/extracellular signal-regulated kinase signal transduction pathway and regulates cell migration, apoptosis, and differentiation. Although a large number of studies have shown that Raf1 is overexpressed in various kinds of c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Fangzheng, Jiang, Chuner, Sun, Quanquan, Yan, Fenqin, Wang, Lei, Fu, Zhenfu, Liu, Tongxin, Hu, Fujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621222/ https://www.ncbi.nlm.nih.gov/pubmed/26527888 http://dx.doi.org/10.2147/OTT.S90710

Ejemplares similares

Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngeal carcinoma
por: Wang, Fangzheng, et al.
Publicado: (2020)

Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
por: Wang, Fangzheng, et al.
Publicado: (2018)

Influence of concurrent chemotherapy on locoregionally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy plus intensity-modulated radiotherapy: A retrospective matched analysis
por: Wang, Fangzheng, et al.
Publicado: (2020)

Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2016)

Treatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy: A Single-Institution Experience
por: Wang, Fangzheng, et al.
Publicado: (2017)

Long-Term Use of Nimotuzumab in Combination With Intensity-Modulated Radiotherapy and Chemotherapy in the Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma: Experience of a Single Institution
por: Fangzheng, Wang, et al.
Publicado: (2018)

Methodology of dose calculation for external beam radiation combined with high dose rate brachytherapy in the era of 3-dimensional treatment planning system
por: Wang, Fangzheng, et al.
Publicado: (2020)

Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With Nasopharyngeal Carcinoma
por: Wang, Fangzheng, et al.
Publicado: (2018)

Survival without concurrent chemotherapy for locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy plus intensity-modulated radiotherapy: Single-center experience from an endemic area
por: Fangzheng, Wang, et al.
Publicado: (2019)

Addition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advanced nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2017)

Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma
por: Wang, Fangzheng, et al.
Publicado: (2017)

Addition of chemotherapy to intensity-modulated radiotherapy does not improve survival in stage II nasopharyngeal carcinoma patients
por: Fangzheng, Wang, et al.
Publicado: (2018)

Addition of 5-fluorouracil to docetaxel/cisplatin does not improve survival in locoregionally advanced nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2017)

Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2017)

Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis
por: Fangzheng, Wang, et al.
Publicado: (2017)

Clinical value of combined detection of miR-1202 and miR-195 in early diagnosis of cervical cancer
por: Yang, Xielan, et al.
Publicado: (2019)

Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma
por: Ye, Zhimin, et al.
Publicado: (2019)

A comparison of neoadjuvant chemotherapy with gemcitabine versus docetaxel plus cisplatin in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis
por: Liu, Tongxin, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy with Fluorouracil plus Nedaplatin or Cisplatin for Locally Advanced Nasopharyngeal Carcinoma: a Retrospective Study
por: Liu, Tongxin, et al.
Publicado: (2018)

Circulating miR-30a, miR-195 and let-7b Associated with Acute Myocardial Infarction
por: Long, Guangwen, et al.
Publicado: (2012)

Optimization of the margin expanded from the clinical to the planned target volume during intensity-modulated radiotherapy for nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2017)

miR-103/miR-195/miR-15b Regulate SALL4 and Inhibit Proliferation and Migration in Glioma
por: Chen, Li-Ping, et al.
Publicado: (2018)

Serum miR‐195‐5p is upregulated in gestational diabetes mellitus
por: Wang, Jianping, et al.
Publicado: (2020)

Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer
por: Zhang, Yujuan, et al.
Publicado: (2015)

miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells
por: Liu, Chunhui, et al.
Publicado: (2015)

A nanomicelle with miR-34a and doxorubicin reverses the drug resistance of cisplatin in esophageal carcinoma cells by inhibiting SIRT1 signal pathway
por: Fang, Jun, et al.
Publicado: (2020)

ZNF367 Inhibits Cancer Progression and Is Targeted by miR-195
por: Jain, Meenu, et al.
Publicado: (2014)

Decreased expression of miR-195 mediated by hypermethylation promotes osteosarcoma
por: Sun, Tianhao, et al.
Publicado: (2022)

miR-195 Serves as a Tumor Suppressor in the Progression of Liposarcoma by Targeting OSBP
por: Cao, Ye, et al.
Publicado: (2020)

The Usefulness of Pretreatment MR-Based Radiomics on Early Response of Neoadjuvant Chemotherapy in Patients With Locally Advanced Nasopharyngeal Carcinoma
por: Yongfeng, Piao, et al.
Publicado: (2021)

Bioinformatics-based analysis of the lncRNA–miRNA–mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma
por: Ye, Zhimin, et al.
Publicado: (2020)

MiR-195-5p Promotes Cardiomyocyte Hypertrophy by Targeting MFN2 and FBXW7
por: Wang, Lei, et al.
Publicado: (2019)

Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195/miR4668 maturation
por: Guo, Jun, et al.
Publicado: (2018)

Ligand-Dependent Downregulation of Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Role of miR-128 and miR-195
por: Khurana, Madan L., et al.
Publicado: (2022)

MicroRNA Biomarker hsa-miR-195-5p for Detecting the Risk of Lung Cancer
por: Li, Lei, et al.
Publicado: (2020)

Clinical significance of miR-195 in hepatocellular carcinoma and its biological function in tumor progression
por: Chen, Xiaoyan, et al.
Publicado: (2019)

Circ_LDLR promoted the development of papillary thyroid carcinoma via regulating miR-195-5p/LIPH axis
por: Gui, Xiaolong, et al.
Publicado: (2020)

miR-195-5p regulates cell proliferation, apoptosis, and invasion of thyroid cancer by targeting telomerase reverse transcriptase
por: Liu, Zhiwen, et al.
Publicado: (2021)

Different Risk Target Volumes for Nasopharyngeal Carcinoma Treated with Simultaneous Integrated Boost Intensity-Modulated Radiotherapy
por: Wang, Fangzheng, et al.
Publicado: (2020)

MiR-195 suppresses non-small cell lung cancer by targeting CHEK1
por: Liu, Ben, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ujlmnfovbti48usi37h8nh261f